- Home
- MCRI vs AORT Comparison
MCRI vs AORT Comparison
Compare MCRI & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- AORT
- Stock Information
- Founded
- MCRI 1972
- AORT 1984
- Country
- MCRI United States
- AORT United States
- Employees
- MCRI N/A
- AORT N/A
- Industry
- MCRI Hotels/Resorts
- AORT Medical/Dental Instruments
- Sector
- MCRI Consumer Discretionary
- AORT Health Care
- Exchange
- MCRI Nasdaq
- AORT Nasdaq
- Market Cap
- MCRI 1.6B
- AORT 1.4B
- IPO Year
- MCRI 1993
- AORT 1993
- Fundamental
- Price
- MCRI $86.57
- AORT $31.35
- Analyst Decision
- MCRI Hold
- AORT Strong Buy
- Analyst Count
- MCRI 5
- AORT 5
- Target Price
- MCRI $88.60
- AORT $32.40
- AVG Volume (30 Days)
- MCRI 110.0K
- AORT 352.4K
- Earning Date
- MCRI 07-16-2025
- AORT 08-07-2025
- Dividend Yield
- MCRI 1.39%
- AORT N/A
- EPS Growth
- MCRI N/A
- AORT N/A
- EPS
- MCRI 3.96
- AORT N/A
- Revenue
- MCRI $525,923,000.00
- AORT $390,084,000.00
- Revenue This Year
- MCRI $4.32
- AORT $12.18
- Revenue Next Year
- MCRI $2.41
- AORT $10.39
- P/E Ratio
- MCRI $21.75
- AORT N/A
- Revenue Growth
- MCRI 3.84
- AORT 5.94
- 52 Week Low
- MCRI $67.14
- AORT $21.97
- 52 Week High
- MCRI $96.11
- AORT $32.94
- Technical
- Relative Strength Index (RSI)
- MCRI 51.87
- AORT 61.69
- Support Level
- MCRI $86.11
- AORT $30.79
- Resistance Level
- MCRI $90.36
- AORT $32.94
- Average True Range (ATR)
- MCRI 1.83
- AORT 0.74
- MACD
- MCRI -0.27
- AORT 0.01
- Stochastic Oscillator
- MCRI 27.89
- AORT 59.03
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.